By Product-
By Route of Administration-
By Facility of Use-
By Region-
North America-
Europe-
Asia-Pacific-
Latin America-
Middle East & Africa-
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Topical Drug Delivery Market Snapshot
Chapter 4. Global Topical Drug Delivery Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis
Chapter 5. Market Segmentation 1: By Product Estimates & Trend Analysis
5.1. By Product, & Market Share, 2020 & 2031
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Product:
5.2.1. Semi-Solid Formulations
5.2.1.1. Creams
5.2.1.2. Ointments
5.2.1.3. Lotions
5.2.1.4. Gel
5.2.1.5. Pastes
5.2.2. Liquid Formulations
5.2.2.1. Suspensions
5.2.2.2. Solutions
5.2.3. Solid Formulations
5.2.3.1. Powders
5.2.3.2. Suppositories
5.2.4. Transdermal Products
5.2.4.1. Transdermal Patches
5.2.4.2. Transdermal Semi-Solids
Chapter 6. Market Segmentation 2: By Route of Administration Estimates & Trend Analysis
6.1. By Route of Administration & Market Share, 2020 & 2031
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Route of Administration:
6.2.1. Dermal Drug Delivery
6.2.2. Ophthalmic Drug Delivery
6.2.3. Rectal Drug Delivery
6.2.4. Vaginal Drug Delivery
6.2.5. Nasal Drug Delivery
Chapter 7. Market Segmentation 3: By Facility of Use Estimates & Trend Analysis
7.1. By Facility of Use & Market Share, 2020 & 2031
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2020 to 2031 for the following By Facility of Use:
7.2.1. Home Care Settings
7.2.2. Hospitals & Clinics
7.2.3. Burn Centers
7.2.4. Other Facilities
Chapter 8. Topical Drug Delivery Market Segmentation 4: Regional Estimates & Trend Analysis
8.1. North America
8.1.1. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Product, 2019-2031
8.1.2. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Route of Administration, 2019-2031
8.1.3. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts By Facility of Use, 2019-2031
8.1.4. North America Topical Drug Delivery Market revenue (US$ Million) estimates and forecasts by country, 2019-2031
8.2. Europe
8.2.1. Europe Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.2.2. Europe Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.2.3. Europe Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.2.4. Europe Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.3. Asia Pacific
8.3.1. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Product, 2019-2031
8.3.2. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, 2019-2031
8.3.3. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, 2019-2031
8.3.4. Asia Pacific Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.4. Latin America
8.4.1. Latin America Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.4.2. Latin America Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.4.3. Latin America Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.4.4. Latin America Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
8.5. Middle East & Africa
8.5.1. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Product, (US$ Million) 2019-2031
8.5.2. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Route of Administration, (US$ Million) 2019-2031
8.5.3. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) By Facility of Use, (US$ Million) 2019-2031
8.5.4. Middle East & Africa Topical Drug Delivery Market revenue (US$ Million) by country, 2019-2031
Chapter 9. Competitive Landscape
9.1. Major Mergers and Acquisitions/Strategic Alliances
9.2. Company Profiles
9.2.1. 3M
9.2.2. AbbVie Inc.
9.2.3. Bausch Health Companies Inc.
9.2.4. Bayer AG
9.2.5. Boehringer Ingelheim International GmBH
9.2.6. Bristol Myers Squibb
9.2.7. Cipla
9.2.8. CMP Pharma, Inc.
9.2.9. Crescita Therpeautics Inc.
9.2.10. Encore Dermatology, Inc.
9.2.11. Galderma
9.2.12. GlaxoSmithKline Plc.
9.2.13. Glenmark Pharmaceuticals Ltd.
9.2.14. Hisamitsu Pharmaceuticals Inc.
9.2.15. Johnson & Johnson Private Limited
9.2.16. Lavipharm
9.2.17. Lead Chemical Co., Ltd.
9.2.18. Merck & Co.Inc..
9.2.19. Novartis International AG
9.2.20. Pfizer Inc.
9.2.21. Prosolus Inc.
9.2.22. Purdue Pharma L.P.
9.2.23. Rusan Pharma Ltd.
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.